Treating laryngeal cancer early and precisely can preserve patients’ ability to speak and swallow. Bharat Panuganti, M.D., discusses the innovations in transoral laser microsurgery (TLM) that have made it an alternative to radiotherapy for treating early-staged laryngeal cancer. He discusses his use of the potassium titanyl phosphate (KTP) laser in this procedure, which targets hemoglobin in the cancerous tissue and limits damage to non-cancerous tissue. Learn more about the current importance of surgeon experience in performing TLM successfully, as well as the research Dr. Panuganti is conducting to possibly use robotics to close that experience gap.
